The U.S. Food and Drug Administration approved leukemia drug Tasigna (generic name: nilotinib) in 2007. In 2015, however, the FDA …
FDA Approves Actemra for Cytokine Release Syndrome
In August, the U.S. Food and Drug Administration (FDA) approved Actemra to treat CAR T cell-induced cytokine release syndrome (CRS). …
Invokana Litigation Update: 55 Claims Consolidated Under MDL 2750
Best-selling blood sugar drug Invokana® (generic: canagliflozin) can cause complications such as ketoacidosis and liver damage. Type 2 diabetics began …
Which Type 2 Diabetes Drug Is Right For You?
Type 2 diabetes is debilitating for many, ushering in a world of needles, side effects and medications. Since insulin resistance …
Device Manufacturer Cook Medical Named in IVC Filter Bellwether Trials
Once a judge consolidates similar lawsuits under a multidistrict litigation, he or she also selects cases for bellwether trials. These …
Experts Weigh In on Invokana Strokes and Consumer Safety
Diabetics constantly need exceptional care and help regulating blood glucose levels. But new, popular drug Invokana (canagliflozin) is making experts …
Invokana Ketoacidosis: Acetone Breath & Hyperglycemia
Invokana ketoacidosis (DKA) is a serious and potentially fatal condition. Though diabetic keotacidosis isn’t uncommon in type 1 diabetics, it’s …
Invokana Heart Attack: What You Need to Know
Once your blood clots, it can cause a chain reaction leading to an Invokana heart attack. Invokana is an SGLT2 …
Yaz Lawsuit Settlement Information—Who, Why, and How Much
In 2011, the U.S. Food and Drug Administration released study results on Yaz birth control. Those results showed women taking …
How to Decide: Anticoagulant Therapy vs. IVC Filters
Stroke survivors know that if the universe could fire bullets, they’ve just dodged one. Imagining another stroke brings a rush …